Related Experiment Video

Updated: Jan 11, 2026

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells
11:47

Real-time Live-cell Flow Cytometry to Investigate Calcium Influx, Pore Formation, and Phagocytosis by P2X7 Receptors in Adult Neural Progenitor Cells

Published on: April 3, 2019

9.7K

Genetic Variations in the P2X7 Receptor: Opportunities and Challenges for Drug Development

Justin S Y Cheah1,2, Kristen K Skarratt3, Stephen J Fuller3

  • 1Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

International Journal of Molecular Sciences
|November 13, 2025
PubMed

Insights

Genetic variations in the P2X7 receptor (P2X7R) likely explain why drugs targeting it failed in clinical trials. Understanding P2X7R diversity is crucial for future therapeutic success in inflammation and neurological disorders.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Immunology

Background:

  • The P2X7 receptor (P2X7R) is a critical component of the cellular stress response, activated by extracellular ATP.
  • Its involvement in inflammation and neurological disorders makes it a promising therapeutic target.
  • Previous clinical trials using P2X7R antagonists have unfortunately yielded limited success.

Purpose of the Study:

  • To investigate the potential reasons for the lack of clinical efficacy in P2X7R antagonist trials.
  • To explore the impact of receptor polymorphisms, alternative splicing, and membrane composition on P2X7R function.
  • To identify strategies for improving the precision targeting of P2X7R in disease states.

Main Methods:

  • Review of existing literature on P2X7R genetics, splicing, and membrane interactions.
  • Analysis of factors contributing to clinical trial outcomes.
  • Discussion of structural findings and computational approaches for P2X7R research.

Main Results:

  • Receptor polymorphisms, alternative splicing, and cell membrane composition are identified as significant factors influencing P2X7R function.
  • Genetic variability in P2X7R is proposed as a major reason for the failure of clinical trials.
  • Gaps in understanding receptor haplotypes and splice variants hinder drug development.

Conclusions:

  • Genotyping trial participants is recommended before enrollment to account for P2X7R genetic variability.
  • In vitro studies must consider the membrane composition of cells expressing P2X7R.
  • A comprehensive, collaborative approach is needed to precisely target P2X7R, leveraging computational methods to address variability and improve therapeutic outcomes.
Keywords:
P2X7 receptorallosteric modulationalternative splicingextracellular signalinghaplotypesingle nucleotide polymorphism

More Related Videos

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels16:36

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels

Published on: May 18, 2009

15.1K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.3K

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.5K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.4K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.8K